Raven Biotechnologies, Inc.
1140 Veterans Boulevard
South San Francisco
California
94080
United States
Tel: 650-624-2600
Fax: 650-553-9169
Website: http://www.ravenbio.com/
Email: info@ravenbio.com
28 articles about Raven Biotechnologies, Inc.
-
VaxGen, Inc. Receives Repayment in Full of Bridge Loan to Raven Biotechnologies, Inc.
7/18/2008
-
MacroGenics, Inc. (JOBS) Acquires Raven Biotechnologies, Inc.
7/17/2008
-
Raven Biotechnologies, Inc. Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies
4/8/2008
-
Raven Biotechnologies, Inc. and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
4/4/2008
-
VaxGen, Inc. and Raven Biotechnologies, Inc. Terminate Merger Agreement
3/28/2008
-
VaxGen, Inc. Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven Biotechnologies, Inc.
3/21/2008
-
MedCap Corp. Urges Vote Against Proposed VaxGen, Inc. Merger With Raven Biotechnologies, Inc.
3/20/2008
-
Raven Biotechnologies, Inc. Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
3/13/2008
-
Raven Biotechnologies, Inc. Advances RAV18 Through Agreement With CMC ICOS Biologics
3/12/2008
-
Raven Biotechnologies, Inc. Announces RAV12 Phase 1/2a Study Results To Be Presented at American Society of Clinical Oncology
3/11/2008
-
Raven Biotechnologies, Inc. Announces Cancer Stem Cell Collaboration With Emory University Medical School
3/3/2008
-
Momentum Continues for Merger of VaxGen, Inc. and Raven Biotechnologies, Inc.
2/21/2008
-
Raven Biotechnologies, Inc. Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
2/13/2008
-
Raven Biotechnologies, Inc. to Provide Updates on Oncology Pipeline With Four AACR Presentations
2/12/2008
-
VaxGen, Inc. and Raven Biotechnologies, Inc. Announce Form S4 Registration Statement Declared Effective
2/11/2008
-
VaxGen, Inc. Provides Update on Raven Biotechnologies, Inc. Transaction Progress
1/7/2008
-
MedCap Opposes VaxGen, Inc.'s Proposed Merger with Raven Biotechnologies, Inc.
12/27/2007
-
MPM BioEquities Demands VaxGen, Inc. Drop Merger Plan with Raven Biotechnologies, Inc.
12/12/2007
-
Raven Biotechnologies, Inc. and Wyeth Extend Evaluation Period of Selected Raven Antibodies
12/6/2007
-
Raven Biotechnologies, Inc. Announces Appointment of Michael Kranda as Chairman of the Board
11/30/2007